Healthcare -
Biotechnology - NASDAQ - US
$ 5.59
1.64 %
$ 343 M
Market Cap
-3.14
P/E
GLUE - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities GLUE - Monte Rosa Therapeutics, Inc.
88.8 M
LAST VALUE
234.65%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR